combined allergic rhinitis and asthma syndrome, CARAS
Conditions
Interventions
Sponsors
The First Affiliated Hospital of Henan University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Patients with AR, BA and CARAS who meet the Western medical diagnostic criteria; (2) Chinese medical evidence consistent with lung qi deficiency evidence, phlegm-heat congestion of the lung evidence or wind-heat offending the lung evidence; (3) Age 18 to 80 years; (4) Voluntarily accepted the study and signed an informed consent form; (5) Not participated in other clinical studies within 1 month prior to enrollment.
Exclusion criteria
Exclusion criteria: (1) Patients with combined vasomotor rhinitis and eosinophilic non-allergic rhinitis, other non-allergic rhinitis diseases that can cause symptoms such as nasal congestion and runny nose; (2) Patients who are participating in other drug trials; (3) Patients with a combination of other serious systemic diseases; (4) Pregnant or lactating women; (5) Patients with confusion, disorders of consciousness, dementia, and various psychiatric disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Interleukin-2,4,5,13 (IL-2,4,5,13);Interferon-?, IFN-?;Tumor Necrosis Factor-ß, TNF-ß;Eosinophil Cationic Protein, ECP;Forced expiratory volume in one second / forced vital capacity, FEV1/FVC; | — |
Secondary
| Measure | Time frame |
|---|---|
| Fractional exhaled nitric oxide, FeNO;Forced vital capacity, FVC;Forced expiratory volume in one second, FEV1;Percentage of forced expiratory volume in one second to predicted value, FEV1% pred; | — |
Countries
China
Contacts
Public ContactYanmin Shi, Yang Xie
The First Affiliated Hospital of Henan University of Chinese Medicine
Outcome results
None listed